mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.4 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
-0.13 |
0.4 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BMS-754807 |
FIMM |
pan-cancer |
AAC |
-0.11 |
0.4 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |